Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Xtant Medical Holdings Inc (XTNT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3506
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

Xtant Medical Holdings Inc (XTNT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 11
Bacterin International Raises USD6.5 Million in Public Offering of Shares 12
Bacterin International Completes Private Placement Of Shares For US$4 Million 14
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 15
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 16
Debt Offering 17
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 17
Xtant Medical Holdings Inc – Key Competitors 18
Xtant Medical Holdings Inc – Key Employees 19
Xtant Medical Holdings Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Oct 06, 2017: Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility 21
Financial Announcements 22
Aug 07, 2018: Xtant Medical announces second quarter 2018 financial results 22
May 08, 2018: Xtant Medical Announces First Quarter 2018 Financial Results 24
Apr 02, 2018: Xtant Announces Fourth Quarter and Year End 2017 Financial Results 26
Nov 21, 2017: Xtant Medical Reports Third Quarter 2017 Financial Results 29
Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 31
May 09, 2017: Xtant Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period 32
Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period 33
Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 35
Corporate Communications 36
Aug 20, 2018: Xtant Medical appoints Kathie Lenzen as Chief Financial Officer 36
Jul 10, 2018: Xtant Medical Names Kevin Brandt As Chief Commercial Officer 37
Feb 22, 2017: Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO 38
Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 11
Bacterin International Raises USD6.5 Million in Public Offering of Shares 12
Bacterin International Completes Private Placement Of Shares For US$4 Million 14
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 15
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 16
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 17
Xtant Medical Holdings Inc, Key Competitors 18
Xtant Medical Holdings Inc, Key Employees 19
Xtant Medical Holdings Inc, Subsidiaries 20

List of Figures
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務分析
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Bawag Psk:企業の戦略・SWOT・財務分析
    Bawag Psk - Strategy, SWOT and Corporate Finance Report Summary Bawag Psk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Infor Global Solutions Inc:企業の戦略的SWOT分析
    Infor Global Solutions Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ark Restaurants Corp. (ARKR):企業の財務・戦略的SWOT分析
    Ark Restaurants Corp. (ARKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Kunlun Energy Co Ltd (135):石油・ガス:M&Aディール及び事業提携情報
    Summary Kunlun Energy Co Ltd (Kunlun), formerly CNPC (Hong Kong) Ltd, a subsidiary of PetroChina Company Ltd, is an integrated oil and gas company that explores and produces crude oil and natural gas. The company also operates natural gas pipelines, LNG processing and storage facilities and conducts …
  • Avista Corporation:企業の戦略・SWOT・財務分析
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Allergan Plc (AGN):医療機器:M&Aディール及び事業提携情報
    Summary Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology …
  • Savencia SA:企業の戦略・SWOT・財務情報
    Savencia SA - Strategy, SWOT and Corporate Finance Report Summary Savencia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Air T Inc:企業の戦略・SWOT・財務分析
    Air T Inc - Strategy, SWOT and Corporate Finance Report Summary Air T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Pyxus International Inc:企業の戦略・SWOT・財務情報
    Pyxus International Inc - Strategy, SWOT and Corporate Finance Report Summary Pyxus International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Toro Energy Limited (TOE):企業の戦略的SWOT分析
    Toro Energy Limited (TOE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kohinoor Energy Limited (KOHE):企業の財務・戦略的SWOT分析
    Kohinoor Energy Limited (KOHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Europ Assistance Holding SA:企業の戦略的SWOT分析
    Europ Assistance Holding SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Terumo Cardiovascular Systems Corp:企業の戦略的SWOT分析
    Terumo Cardiovascular Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Wirecard AG:企業の戦略・SWOT・財務分析
    Wirecard AG - Strategy, SWOT and Corporate Finance Report Summary Wirecard AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • United States Postal Service:企業の戦略的SWOT分析
    United States Postal Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Grant Thornton International Ltd.:企業の戦略・SWOT・財務分析
    Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Grant Thornton International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • EIH Associated Hotels Ltd.:企業の戦略・SWOT・財務情報
    EIH Associated Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary EIH Associated Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • New Gold Inc:企業の戦略・SWOT・財務分析
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ERI Bancaire SA:企業の戦略的SWOT分析
    ERI Bancaire SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆